Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB05271_DB08920_nanopub.RA07Lm3euze5F_QD3HvLK7Ao1Mqjrg_FUjhFO7ae5J-QI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB05271_DB08920 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB05271_DB08920 label "DDI between Rotigotine and Zuclopenthixol decanoate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and rotigotine, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. [drugbank_resource:DB05271_DB08920]" assertion.
- drugbank_resource:DB05271_DB08920 identifier "drugbank_resource:DB05271_DB08920" assertion.
- drugbank_resource:DB05271_DB08920 title "DDI between Rotigotine and Zuclopenthixol decanoate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and rotigotine, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed." assertion.
- drugbank:DB08920 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB05271_DB08920 assertion.
- drugbank:DB05271 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB05271_DB08920 assertion.